NEW YORK (Reuters Health)—Patients with active rheumatoid arthritis (RA) and no known heart disease may have subclinical myocardial inflammation, which improves with disease-modifying therapy, new research shows. “We know that patients with RA have higher risk of cardiovascular events, including heart failure and we really don’t know why. Maybe myocardial inflammation is one of the…
Updated Guidelines and New Therapies for Osteoporosis Coming this Year
Updated guidelines, online assessment tool, and new therapies coming this year
Birthday in Bean Town
As TR celebrates one year, we look forward to an exciting 2008
Changes and Choices for Clinicians
Clinician members will have more than enough sessions to keep them busy at the ACR Annual Scientific Meeting in Boston this November. The Annual Meeting Planning Committee (AMPC) continues to use attendee feedback and member input to create a meeting that offers vital content to every attendee.
ACR Meeting: 1975 to Now
We’ve has come a long way, but 2007 holds more growth